klionpd.blogg.se - Narcolepsy without cataplexy treatment

Averill, MDĬontact: Catherine Goodwin 40 Investigator: Thomas W. Lorch, Jr, MDĬlearwater, Florida, United States, 33765Ĭontact: Cherrie Laner 72 Investigator: Francis J. Green, III, MDĬontact: Kelly Henderson 81 Investigator: Dragos Zanchi, MDĬontact: Francoise Poli 81 Investigator: Daniel G. Santa Ana, California, United States, 92705Ĭontact: Johnny Salvador 71 Investigator: Andrew O. San Diego, California, United States, 92103Ĭontact: Lauren Martinez 61 Investigator: Stephen G. Los Angeles, California, United States, 90048-6138Ĭontact: Sonia Soto 31 Investigator: Roy Artal, MD Southern California Institute for Respiratory Diseases, Inc. Los Angeles, California, United States, 90025Ĭontact: Maha Kazim 31 Investigator: Daniel Norman, MD

An occupation requiring variable shift work, night shifts, or frequent overnight travel which disrupts sleep patterns.īirmingham, Alabama, United States, 35213Ĭontact: Wes Booth 20 Investigator: Robert C.

Clinically significant ECG abnormalities.

Current diagnosis of or past treatment for syndromes known to cause sleep disruption or any other cause of daytime sleepiness.

Use of concurrent medications prescribed to treat narcolepsy as specified including stimulants, antidepressants and sodium oxybate.Nicotine dependence that has an effect on sleep (eg, a patient who routinely awakens at night to smoke).An ESS score of ≥ 12 and mean MWT time of 600 mg/per day) use at least 1 week prior to baseline assessments and during the course of the trial.Have undergone a multiple sleep latency test (MSLT) study showing an MSLT of ≤ 8 minutes.Have narcolepsy with or without cataplexy (Na-1 or Na-2) based on the International Classification of Sleep Disorders (3rd edition) criteria (new or previously diagnosed).

Ages of 18 to 65 years (adult), inclusive.Why Should I Register and Submit Results?.